These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 12584269

  • 1. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT, Ottosen P, Starklint H, Dieperink H.
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [Abstract] [Full Text] [Related]

  • 2. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N, Torras J, Alperovich G, Cruzado JM, Giménez-Bonafé P, Herrero-Fresneda I, Franquesa Ml, Rama I, Grinyó JM.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [Abstract] [Full Text] [Related]

  • 3. Impaired glomerular and tubular function as a short-term effect of sirolimus treatment in the rat.
    Nielsen FT, Starklint H, Dieperink H.
    Am J Nephrol; 2005 Oct; 25(4):411-6. PubMed ID: 16088082
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ, Streit F, Boeger M, Dhein S, Tarnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF.
    Transplantation; 2004 Apr 27; 77(8):1154-62. PubMed ID: 15114077
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 27; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 7. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
    Bai S, Brunner LJ, Stepkowski SM, Napoli KL, Kahan BD.
    Transplantation; 2001 Jun 15; 71(11):1585-92. PubMed ID: 11435969
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.
    Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM.
    Kidney Int; 1996 Oct 15; 50(4):1110-7. PubMed ID: 8887267
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive treatment and progression of histologic lesions in kidney allografts.
    Morales JM.
    Kidney Int Suppl; 2005 Dec 15; (99):S124-30. PubMed ID: 16336565
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 14. Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response.
    Rigol M, Solanes N, Sionis A, Gálvez C, Martorell J, Rojo I, Brunet M, Ramírez J, Roqué M, Roig E, Pérez-Villa F, Barquín L, Pomar JL, Sanz G, Heras M.
    J Heart Lung Transplant; 2008 Apr 15; 27(4):416-22. PubMed ID: 18374878
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
    Goodman GR, Dissanayake IR, Sodam BR, Gorodetsky E, Lu J, Ma YF, Jee WS, Epstein S.
    J Bone Miner Res; 2001 Jan 15; 16(1):72-8. PubMed ID: 11149492
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.
    Ekberg H, Bernasconi C, Nöldeke J, Yussim A, Mjörnstedt L, Erken U, Ketteler M, Navrátil P.
    Nephrol Dial Transplant; 2010 Jun 15; 25(6):2004-10. PubMed ID: 20106825
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.